QD probes directed against vascular endothelial growth factor receptor 2 (VEGFR2) achieved efficient uptake in LNCaP cells and increased tumor-associated fluorescence in both in vitro assays and xenograft models [74]. This evidence concerns the gene KDR and neoplasm.